A phase I dose-escalation trial of 2-deoxy- d-glucose alone or combined with docetaxel in patients with advanced solid tumors.

Autor:	Raez, Luis1, Papadopoulos, Kyriakos2, Ricart, Alejandro2, Chiorean, E.3, DiPaola, Robert4, Stein, Mark4, Rocha Lima, Caio1, Schlesselman, James1, Tolba, Khaled1, Langmuir, Virginia5, Kroll, Stewart5, Jung, Donald5, Kurtoglu, Metin6, Rosenblatt, Joseph1, Lampidis, Theodore6 tlampidi@med.miami.edu
Zdroj:	Cancer Chemotherapy & Pharmacology. Feb2013, Vol. 71 Issue 2, p523-530. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink